Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of arsenic trioxide in treating children who have advanced neuroblastoma or other solid tumors.
Epistemonikos ID: 6a65ffece5cc4fad1d62a20c685841fcce5a8ef5
First added on: May 03, 2024